Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-18-001566
Filing Date
2018-10-31
Accepted
2018-10-31 16:00:22
Documents
1
Period of Report
2018-10-29

Document Format Files

Seq Description Document Type Size
1 form4-10312018_041007.html 4  
1 form4-10312018_041007.xml 4 4107
  Complete submission text file 0001415889-18-001566.txt   5428
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Curran Terrie (Reporting) CIK: 0001690298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34912 | Film No.: 181150251